Aculys Pharma and SUSMED Have Entered into a Contract to Conduct the World’s First Clinical Trial Utilizing Blockchain Technology
– Introducing digital transformation (DX) for monitoring work and reducing new drug development costs – TOKYO–(BUSINESS WIRE)–Aculys Pharma, Inc. (“Aculys Pharma” Headquarters: Minato-ku, Tokyo, President and CEO: Kazunari Tsunaba), a company focused on the development and commercialization of new innovative drugs in the fields of neurology and psychiatry, has entered into a contract with SUSMED, … [Read more…]